MEDP

NASD Medpace Holdings, Inc.

Oct 23, 2026 · 11:09 AM ET DELAYED Market Open

$657.41 ↑ +3.44 (+0.53%) Trading Up from the previous close of $653.96, $1.07 below the day’s high of $658.47

YTD change: +17.05%
vs 20-day SMA: +6.26%
vs 200-day SMA: +24.67%

Price ranges

Previous day

$645.30 $684.52

open $657.11 close $653.96

-$3.15 (-0.48%)

Today

$645.93 $658.47

open $654.98 now $657.41

+$2.42 (+0.37%)

Past week

$610.05 $684.52

from $628.60 now $657.41

+$28.81 (+4.58%)

Past month

$587.39 $684.52

from $620.59 now $657.41

+$36.81 (+5.93%)

This year

$373.00 $684.52

from $561.65 now $657.41

+$95.76 (+17.05%)

Price & Performance

+260.54 (+66.22%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 4.0% away from all-time highs of $684.52
MEDP is up 17% since the beginning of the year
MEDP is up 10% over the past 12 months
MEDP is up 6% over the past 1 month
7% of all MEDP investors are betting against MEDP

MEDP reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +9.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $4.84

Earnings momentum +11.5% Quarterly EPS growth

Quarterly change +11.5%

Valuation

P/E ratio 38.90

Enterprise value $18.0B

Beta 0.70

Balance sheet & scale

Income$517.8K

Revenue$2.8B

Cash$705.3M

Debt$146.0K

Income / Debt 3.55×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Professional, Scientific, and Technical Services

Industry Group Scientific Research and Development Services

Market cap $18.3B

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: North America, Europe, Asia, South America, Africa and Australia. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.

Competitor comparison

Ticker	Company	Price	Change
AMGN	Amgen Inc.	$447.28	+2.04%
MRNA	Moderna, Inc.	$202.63	-17.57%
RVMD	Revolution Medicines, Inc.	$187.69	-3.39%
ROIV	Roivant Sciences Ltd.	$37.45	+1.77%
BNTX	BioNTech SE Sponsored ADR	$89.67	-1.77%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.